Fiche société
AHS Cancer Control Alberta
Traitements, essais et publications liés.
Traitements14programmes
Essais12liés
Publications0liées
SourceDBlocale
Traitements
14| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| ErlotinibThis study is to determine the use of theophylline in patients with NSCLC and advanced solid malignancies and whether treatment with theophylline will help lower or diminish the side effect of diarrhea in patients taking erlotinib. Patients will be enrolled in one of two parts of the study to verify the lowest dose of theophylline that is effective and the highest dose of erlotinib that can be tolerated with theophylline. If this study shows that theophylline is able to inhibit erlotinib induced diarrhea, it will help demonstrate that patients using the tyrosine kinase inhibitor (TKIs), erlotinib, can use it effectively at higher doses without experiencing severe diarrhea. | SEP | Phase 1 | À vérifier | Canada | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Phase 1 | À vérifier | Canada | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Non applicable | À vérifier | China | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Phase 4 | À vérifier | China | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Phase 4 | À vérifier | United States | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Non applicable | À vérifier | Spain | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Non applicable | À vérifier | Israel | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Phase 3 | À vérifier | United States | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Phase 2 | À vérifier | United States | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Non applicable | À vérifier | Finland | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Phase 2/3 | À vérifier | Canada | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Phase 4 | À vérifier | United States | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Phase 4 | À vérifier | Australia | À vérifier |
| TheophyllineTo evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of theophylline. | SEP | Phase 1 | À vérifier | Canada | À vérifier |
Essais cliniques
12| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Theophylline | SEP | Phase 1 | NCT02080078 | A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline | TERMINATED |
| Theophylline | SEP | Phase 4 | NCT02261727 | TASCS — Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) Study | COMPLETED |
| Theophylline | SEP | Phase 4 | NCT01601132 | Drug Interaction Study of Colchicine and Theophylline | COMPLETED |
| Theophylline | SEP | Phase 2/3 | NCT01066728 | CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity | COMPLETED |
| Theophylline | SEP | Non applicable | NCT03115294 | CardiomeDIC — Digital Image Correlation in Right Ventricular Evaluation | COMPLETED |
| Theophylline | SEP | Phase 2 | NCT04551170 | Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old | ACTIVE_NOT_RECRUITING |
| Theophylline | SEP | Phase 3 | NCT02340520 | Enhancement of Corticosteroid Efficacy in COPD | COMPLETED |
| Theophylline | SEP | Non applicable | NCT00893009 | The Effect on Small Airways of Addition of Theophylline as Inducer of Histone Deacilase Activity for Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Treated With Inhaled Steroids and Long Acting Beta Agonists | UNKNOWN |
| Theophylline | SEP | Non applicable | NCT00671151 | Effects of Low-Dose Theophylline During Chronic Obstructive Pulmonary Disease (COPD) Exacerbations | COMPLETED |
| Theophylline | SEP | Phase 4 | NCT03718403 | Effect of Theophylline in Pseudohypoparathyroidism | RECRUITING |
| Theophylline | SEP | Phase 4 | NCT01684683 | The Effect of Theophylline in the Treatment of Bronchiectasis | COMPLETED |
| Theophylline | SEP | Non applicable | NCT02001935 | Association Between CytochromeP4501A2 and CytochromeP4502E1 Gene Polymorphisms and Metabolism of Theophylline | COMPLETED |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||